Research News

While a great deal of the excitement about advances in psychological treatments comes from the potential for research in neuroscience to unlock the secrets of the brain, many mental health experts would like to temper this enthusiasm. A special issue of the Behavior Therapist released this month calls into question the predominant conception of mental illnesses as brain disorders.

New research finds that the non-physical aspects of withdrawal from SSRIs are often overlooked.

In JAMA Psychiatry, prominent psychiatrist Kenneth Kendler writes that psychiatric diagnoses are “working hypotheses, subject to change.”

MIA’s Ayurdhi Dhar interviews Joseph Gone about how a history of dispossession, conquest, and colonization shapes mental health outcomes in Native American communities.

A new study highlights the role heavy metal music plays in the mental health of adolescents facing adversity.

Mixed-Methods study explores the experiences of antipsychotic discontinuation among service users.

Researchers explore neoliberal influences on interactions in psychotherapy and question whether the radical potential of psychotherapy can counter prevailing social systems.

Without clarity and consensus around what social justice means, psychologists risk perpetuating injustices that undermine their stated mission.

Dr. Yolande Lucire, a psychiatrist from Australia, recently published a paper about the iatrogenic effects of psychiatric drugs.

The alternative treatment model of Soteria helps individuals suffering from schizophrenia without relying on medication or coercion.

Researchers find that nearly half of cognitive behavioral therapy (CBT) patients experience treatment side effects.

People who take anticholinergic drugs, such as antidepressants and antipsychotics, are at a 50% higher risk of dementia.

Survey examines adverse personal and interpersonal effects of antidepressants and the impact of polypharmacy

Study finds that 74% of patients with a psychotic disorder off antipsychotics at end of 10 years are in remission.

Data shows that over a third of users experience permanent memory loss and that approximately half report not receiving adequate information about the risks from their doctors.

Post-SSRI sexual dysfunction (PSSD) may be a common adverse effect of antidepressants. Researchers are now attempting to understand the neurobiology behind it.

Lithium appears to reduce libido and sexual function, and more research into the problem is needed.

Selective serotonin reuptake inhibitors (such as Prozac and Zoloft) are the most commonly prescribed medication for depression. SSRIs have long been associated with an...

Effects of discontinuing SSRIs and SNRIs reported on an online forum indicate significant and long-lasting withdrawal symptoms.

Researchers found acupuncture effective in the treatment of chronic pain and depression

Researchers review a new synthesis of the existing evidence and conclude that the harms of antidepressants outweigh any benefits.

Interviews with psychosocially oriented psychologists demonstrate their experiences of discomfort with the hegemony of the medical model in their place of work and the conflicts that arise when they attempt to provide alternatives.

Prior use of benzodiazepines, such as Xanax, Librium, or Ativan, may increase the risk of treatment-resistant depression (TRD), according to a new study published in The Journal of Nervous and Mental Disease.

A recent RCT showed that vitamin B6 is as effective as propranolol for the treatment of akathisia.

Researchers find that support and self-care were helpful for users during discontinuation, but that mental health professionals were not very helpful.